CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 36 enrolled
Drug / intervention
Ulipristal Acetate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02577601
NCT02577601Phase 4Completed
CompareCT.gov

Determining the Impact of Combined Hormonal Contraceptives on Ulipristal Acetate

Oregon Health and Science University·interventional·Posted Oct 16, 2015·Updated Nov 8, 2019

In Brief

A Phase 4 clinical trial evaluating Ulipristal Acetate and Levonorgestrel (LNG)/Ethinyl estradiol birth control pill for Contraception. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The purpose of this research study is to determine if taking a birth control pill effects how well an emergency contraceptive pill called Ulipristal acetate (UPA) works. This type of emergency contraceptive is the most effective oral method available. However, this medication is an anti-progestin and most regular forms of birth control contain progestin (a female hormone). It is unknown if taking the two close together may make the emergency contraceptive not work well. The overall goal of this research is to improve the effectiveness of contraception for women and to better counsel women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesUnited States
CollaboratorsSociety of Family Planning

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 16, 2015
Enrollment StartSep 8, 2015
Primary CompletionJun 17, 2017
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.7 years ago

Interventions

Ulipristal Acetatedrug

Levonorgestrel (LNG)/Ethinyl estradiol birth control pilldrug